TTM
$7.49
YoY change
+1.6%
5Y CAGR
+8.3%
Peak year (2021)
$8.67
Latest annual
$6.80
EPS (Diluted) history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $6.80
EPS (Diluted) growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +1.6%
EPS (Diluted) history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $6.80 | +1.6% | +$0.11 | ||
| 2024 | $6.69 | -15.1% | −$1.19 | ||
| 2023 | $7.88 | +1.9% | +$0.15 | ||
| 2022 | $7.73 | -10.8% | −$0.94 | ||
| 2021 | $8.67 | +89.7% | +$4.10 | ||
| 2020 | $4.57 | +42.4% | +$1.36 | ||
| 2019 | $3.21 | +17.2% | +$0.47 | ||
| 2018 | $2.74 | +37.7% | +$0.75 | ||
| 2017 | $1.99 | +4.2% | +$0.08 | ||
| 2016 | $1.91 | +46.9% | +$0.61 | ||
| 2015 | $1.30 | -25.7% | −$0.45 | ||
| 2014 | $1.75 | +11.5% | +$0.18 | ||
| 2013 | $1.57 | +36.5% | +$0.42 | ||
| 2012 | $1.15 | +6.5% | +$0.07 | ||
| 2011 | $1.08 | +13.7% | +$0.13 | ||
| 2010 | $0.95 | -10.4% | −$0.11 | ||
| 2009 | $1.06 | -15.2% | −$0.19 | ||
| 2008 | $1.25 | +22.5% | +$0.23 | ||
| 2007 | $1.02 | +2.0% | +$0.02 | ||
| 2006 | $1.00 | +40.8% | +$0.29 | ||
| 2005 | $0.71 | +26.8% | +$0.15 | ||
| 2004 | $0.56 | -25.3% | −$0.19 | ||
| 2003 | $0.75 | +127.3% | +$0.42 | ||
| 2002 | $0.33 | -464.2% | +$0.42 | ||
| 2001 | −$0.09 | -462.4% | −$0.12 | ||
| 2000 | $0.03 | -96.1% | −$0.61 | ||
| 1999 | $0.64 | +540.0% | +$0.54 | ||
| 1998 | $0.10 | -85.1% | −$0.57 | ||
| 1997 | $0.67 | +168.0% | +$0.42 | ||
| 1996 | $0.25 | -41.9% | −$0.18 | ||
| 1995 | $0.43 | 0.0% | $0.00 | ||
| 1994 | $0.43 | +16.2% | +$0.06 | ||
| 1993 | $0.37 | +19.4% | +$0.06 | ||
| 1992 | $0.31 | -321.4% | +$0.45 | ||
| 1991 | −$0.14 | -307.4% | −$0.21 | ||
| 1990 | $0.07 | -78.9% | −$0.25 | ||
| 1989 | $0.32 | +18.5% | +$0.05 | ||
| 1988 | $0.27 | +28.6% | +$0.06 | ||
| 1987 | $0.21 | -22.2% | −$0.06 | ||
| 1986 | $0.27 | +12.5% | +$0.03 | ||
| 1985 | $0.24 | — | — |
- 2025$6.80+1.6%
- 2024$6.69-15.1%
- 2023$7.88+1.9%
- 2022$7.73-10.8%
- 2021$8.67+89.7%
- 2020$4.57+42.4%
- 2019$3.21+17.2%
- 2018$2.74+37.7%
- 2017$1.99+4.2%
- 2016$1.91+46.9%
- 2015$1.30-25.7%
- 2014$1.75+11.5%
- 2013$1.57+36.5%
- 2012$1.15+6.5%
- 2011$1.08+13.7%
- 2010$0.95-10.4%
- 2009$1.06-15.2%
- 2008$1.25+22.5%
- 2007$1.02+2.0%
- 2006$1.00+40.8%
- 2005$0.71+26.8%
- 2004$0.56-25.3%
- 2003$0.75+127.3%
- 2002$0.33-464.2%
- 2001−$0.09-462.4%
- 2000$0.03-96.1%
- 1999$0.64+540.0%
- 1998$0.10-85.1%
- 1997$0.67+168.0%
- 1996$0.25-41.9%
- 1995$0.430.0%
- 1994$0.43+16.2%
- 1993$0.37+19.4%
- 1992$0.31-321.4%
- 1991−$0.14-307.4%
- 1990$0.07-78.9%
- 1989$0.32+18.5%
- 1988$0.27+28.6%
- 1987$0.21-22.2%
- 1986$0.27+12.5%
- 1985$0.24—
EPS (Diluted) values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current diluted EPS (TTM) is $7.49. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, West Pharmaceutical Services (WST) diluted EPS totalled $6.80 – edged up 1.6% year-over-year.
Looking at the 2020–2025 (5 years) stretch, West Pharmaceutical Services diluted EPS compounded at +8.3% per year, with mixed annual results across the window.
West Pharmaceutical Services diluted EPS declined from $8.67 in 2021 to $6.80 in 2025, a 21.6% drawdown.
The highest annual diluted EPS of $8.67 was reported in 2021. The lowest in the available history was −$0.14 in 1991.
West Pharmaceutical Services EPS (Diluted) by Year
West Pharmaceutical Services EPS (Diluted) 2025: $6.80
2025's diluted EPS for West Pharmaceutical Services came in at $6.80, edged up 1.6% from 2024.
West Pharmaceutical Services EPS (Diluted) 2024: $6.69
West Pharmaceutical Services posted diluted EPS of $6.69 in 2024, declined 15.1% below 2023.
West Pharmaceutical Services EPS (Diluted) 2023: $7.88
In 2023, West Pharmaceutical Services reported diluted EPS of $7.88, edged up 1.9% from 2022.
West Pharmaceutical Services EPS (Diluted) 2022: $7.73
West Pharmaceutical Services diluted EPS in 2022 was $7.73, declined 10.8% below 2021.
West Pharmaceutical Services EPS (Diluted) 2021: $8.67
West Pharmaceutical Services diluted EPS in 2021 was $8.67.
See more financial history for West Pharmaceutical Services (WST). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation